Tirzepatide Once Weekly for the Treatment of Obesity
In this 72-week trial in participants with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in body weight. (Supported by ...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 2,460
- Institution
- Eli Lilly (United States)
External Links
Identifiers
- ORCID
- 0009-0001-7598-402X
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.